News About: Pharm. Industry
Some pharmaceuticals, ‘Take off group guilt conscience’
‘Rebate, private corporate issue’
(Digital BOSA)
Insisted ‘Let’s Rebates no longer tied to the industrial development’
While pharmaceutical’ rebates news is up through media, some pharmaceuticals insisted th...
Opened Expogi generics market, CJ, Daewon, Kyungdong top 3 players
Exone leading, followed by Excombi, and Baldifin … Expogi still strong
(Medipana)
Since last Octover, among generics of Novartis ‘Exposi’ CJ, Daewon, and Kyungdong are top 3 players revealed.
According to Ubist d...
New Type Rebate Appeared, Salesman at Pharmaceutical Firms Having ‘Two Time Sales’
Receiving Sales Charge of Other Pharmaceutical Firms and Leading Prescription from Doctors.
(Yakup Shinmoon)
Pharmaceutical Firms should not give rebate. However, new type of rebate is continuously appearing.
A...
National Health Insurance Corporation, Losing a Requested Lawsuit against JW Choong-wae Shin-yak
Western Branch of Seoul District Court, Claiming Plaintiff has ‘No Reason’
(Yakup shinmoon)
National Health Insurance Corporation (NHIC) claimed a requested lawsuit against JW Choong-wae Shin-yak. About this, West...
Dongwha Pharm found rebates provided after activation of dual punishment, Fine of 800 million won
Fair Trade Committee open rebates details… Cashable assets. Product seminars over tolerance band.
(medipana)
Dongwha Pharm has been imposed a penalty of 898 million won (KRW) on charges of providing rebates even ...
Because of Economic Recession and Strict Regulation of Rebate, Market of Prescription Drugs is reduc
Because of Economic Recession and Strict Regulation of Rebate, Market of Prescription Drugs is reducing.
On October, 2013, Outpatient Rx is 766.1 billion Won: Compared to 2012, decreased as 1.6%, but Yuhan Corporatio...
Sanofi “Bone cancer cure” development stopped
Due to safety --- side effects reported
(medical pharmaceutical news)
Sanofi stopped all clinical trials and approval process of Fedratinib for rare bone cancer due to safety issue.
This decision was made due t...
As the weather turns cold, the use of Hyperlipidemia medicine is increasing
Pfizer reclaims its top position from the sales increase of Lipitor
(Digital BOSA)
According to the outpatient prescribed medicine report from the financial industry, prescription sales for Hyperlipidemia medicine...
Pharmaceutical Firms: The Best or The Worst? Sighing Deeply concerning their Scenario.
They have trouble with drifting policy of pharmaceutical industry – surging discontent with complete change of regulation.
(Yakup Shinmoon)
The policy of pharmaceutical industry that will be the basis of project o...
Bayer Korea voluntarily recall Ultravist
Concerns such as oil mixed, etc. product return request to wholesalers
(Digial BOSA)
‘Ultravist’, Contrast medium of Bayer, is withdrawn voluntarily.
Bayer Korea sent official letter to customers as well as th...
